During the past decade, Kootenai Health - Coeur d'Alene conducted 173 clinical trials. In the 10-year time frame, 173 clinical trials started and 70 clinical trials were completed, i.e. on average, 40.5% percent of trials that started reached the finish line to date. In the past 5 years, 70 clinical trials started and 59 clinical trials were completed. i.e. 84.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kootenai Health - Coeur d'Alene" #1 sponsor was "National Cancer Institute (NCI)" with 92 trials, followed by "Alliance for Clinical Trials in Oncology" with 40 trials sponsored, "SWOG Cancer Research Network" with 38 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "NRG Oncology" with 18 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kootenai Health - Coeur d'Alene" #1 collaborator was "National Cancer Institute (NCI)" with 112 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Kootenai Health - Coeur d'Alene" are "Invasive Breast Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Metastatic Malignant Neoplasm in the Brain" (6 trials). Many other conditions were trialed in "Kootenai Health - Coeur d'Alene" in a lesser frequency.

Most popular intervention types in "Kootenai Health - Coeur d'Alene" are "Drug" (167 trials), "Other" (125 trials), "Biological" (83 trials), "Procedure" (64 trials) and "Radiation" (26 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (56 trials), "Quality-of-Life Assessment" (51 trials), "Computed Tomography" (32 trials), "Biospecimen Collection" (31 trials) and "Questionnaire Administration" (31 trials). Other intervention names were less common.

The vast majority of trials in "Kootenai Health - Coeur d'Alene" are 180 trials for "All" genders, 35 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Kootenai Health - Coeur d'Alene". undefined are not yet recruiting, 67 are recruiting, 95 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Kootenai Health - Coeur d'Alene, 6 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Kootenai Health - Coeur d'Alene, 9 "Phase 1" clinical trials were conducted, 110 "Phase 2" clinical trials and 100 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".

Kootenai Health - Coeur d'Alene has several departments that took part in Clinical trials: "Kootenai Cancer Clinic" - 277 trials, "Heart Clinics Northwest" - 22 trials, "Kootenai Heart Clinics" - 7 trials